Monographs: Dosage forms: Specific monographs: Dapsone tablets (Dapsoni compressi)

Category. Antileprosy drug.

Additional information. Strengths in the current WHO Model list of essential medicines: 25 mg, 50 mg, 100 mg. Strengths in the current WHO Model list of essential medicines for children: 25 mg, 50 mg, 100 mg.

The tablets may be coloured.

Requirements

Comply with the monograph for Tablets.

Dapsone tablets contain not less than 93.0% and not more than 107.0% of the amount of C12H12N2O2S stated on the label.

Identity tests

  • Either tests A and B or tests B and C may be applied.

A. To a quantity of the powdered tablets equivalent to 0.1 g of Dapsone add 50 mL of methanol R, shake and filter. Dilute 0.5 mL of the filtrate to 200 mL with methanol R. The absorption spectrum of the resulting solution, when observed between 230 nm and 350 nm, exhibits maxima at about 260 nm and 295 nm; the absorbances of a 1 cm layer at these maximum wavelengths are about 0.36 and 0.6, respectively.

B. See the test described below under "Related substances". The principal spot obtained with solution A corresponds in position, appearance and intensity with that obtained with solution B.

C. Shake a quantity of the powdered tablets equivalent to 0.05 g of Dapsone with 5 mL of warm acetone R, filter, evaporate the filtrate and dry at 105 °C for 30 minutes. Dissolve the residue in 2 mL of hydrochloric acid (~70 g/l) TS, cool in ice and add 4 mL of sodium nitrite (10 g/l) TS. Allow to stand for 2 minutes then pour the mixture into 2 mL of freshly prepared 2-naphthol TS1 containing 1 g of sodium acetate R; an orange-red precipitate is produced.

Related substances

Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R1 as the coating substance and a mixture of 8 volumes of toluene R and 4 volumes of acetone R as the mobile phase. Apply separately to the plate 1 μl of each of the following two solutions. For solution (A) shake a quantity of the powdered tablets equivalent to 10 mg of Dapsone with 10 mL of methanol R, filter and use the clear filtrate. For solution (B) dissolve 5 mg of dapsone RS in 5 mL of methanol R. Further apply 10 μl of the following three solutions. For solution (C) shake a quantity of the powdered tablets equivalent to 0.1 g of Dapsone with 10 mL of methanol R, filter and use the clear filtrate. For solution (D) dilute 1 mL of solution C to 100 mL with methanol R and for solution (E) dilute 1 mL of solution D to 5 mL with methanol R. After removing the plate from the chromatographic chamber allow it to dry in air and spray first with sodium nitrite/hydrochloric acid TS and then, while still damp, with N-(1-naphthyl)ethylenediamine hydrochloride (1 g/l) TS, and examine the chromatogram in daylight.

Any spot obtained with solution C, other than the principal spot, is not more intense than that obtained with solution D and not more than two such spots are more intense than that obtained with solution E.

Assay

Weigh and powder 20 tablets. Dissolve a quantity of the powder equivalent to about 0.25 g of Dapsone, accurately weighed, in a mixture of 15 mL of water and 15 mL of hydrochloric acid (~70 g/l) TS. Carry out the assay as described under 2.7 Nitrite titration, titrating with sodium nitrite (0.1 mol/l) VS.

Each mL of sodium nitrite (0.1 mol/l) VS is equivalent to 12.42 mg of C12H12N2O2S.

to previous sectionto next section